Vera Therapeutics VERA Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's net income?
- Vera Therapeutics (VERA) reported net income of -$121.03M in Q1 2026.
- How has Vera Therapeutics's net income changed year-over-year?
- Vera Therapeutics's net income decreased by 134.1% year-over-year, from -$51.69M to -$121.03M.
- What is the long-term trend for Vera Therapeutics's net income?
- Over 4 years (2021 to 2025), Vera Therapeutics's net income has grown at a 74.1% compound annual growth rate (CAGR), from -$32.61M to -$299.62M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.